[Table/Fig-9]:
Comparison between no. of patients developing side effects in each group.
| Side effect | Levocetirizine 5 mg | Ebastine 20 mg |
Ebastine 10 mg |
p-value | |
|---|---|---|---|---|---|
| Dryness | Yes | 47(31.3%) | 23(15.3%) | 20(13.3%) | p<0.001 |
| No | 3(2%) | 27(18%) | 30(20%) | ||
| Sedation | Yes | 42(28%) | 29(19.3%) | 20(13.3%) | p<0.001 |
| No | 8(5.3%) | 21(14%) | 30(20%) | ||
| Drowsiness | Yes | 42(35%) | 21(14%) | 12(8%) | p<0.001 |
| No | 8(5.3%) | 29(19.3%) | 38(25.3%) | ||
| Headache | Yes | 27(18%) | 10(6.6%) | 8(5.3%) | p<0.001 |
| No | 23(15.3%) | 40(26.6%) | 42(28%) |
The difference in the number of patients experiencing side effects is varying for Ebastine 20mg, 10mg and Levocetirizine 5mg. This difference is highly significant (p<0.001) for all the side effects, for all three forms of medication.